PNC Financial Services Group’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
Other funds holding AVBP
IAM
PNC Financial Services Group's AVBP Position: Q3 2026 in Review
PNC Financial Services Group increased its ArriVent BioPharma (AVBP) stake by 53% in Q3 2026, buying an estimated $3.49K and bringing the position to 328 shares worth $9.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4186.
PNC Financial Services Group first reported a position in AVBP in Q3 2025 and has held it in 5 quarters since. 151 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.
- PNC Financial Services Group held 328 shares of ArriVent BioPharma worth $9.9K as of Q3 2026.
- PNC Financial Services Group bought 114 ArriVent BioPharma shares in Q3 2026, an estimated $3.49K.
- ArriVent BioPharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4186 holding.
- PNC Financial Services Group first reported a position in ArriVent BioPharma in Q3 2025 and has held it in 5 quarters since.
- 151 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.